Texas Children's Global Health Global HOPE
Global HOPE
History of Texas Children's Global HOPE Program
Texas Children’s launched the Global HOPE (Hematology-Oncology Pediatric Excellence) Program in 2017 to fulfill its Mission – a healthier future for children across our global community through our leadership in patient care, education and research.
Recognizing the unconscionable survival disparities between high-income and low/middle-income countries for children with cancer and blood diseases, Dr. David G. Poplack initiated Global HOPE and was founding director. His vision was to dramatically improve the survival of children with cancer and blood diseases in Africa, to approximate the survival in the United States.
The Global HOPE Program leveraged the experience and infrastructure of Texas Children’s sister institutions in Africa – the Baylor College of Medicine Children’s Foundations. With support from Bristol Myers Squibb Foundation, Lions Clubs International Foundation, ELMA Philanthropies, Sky High for Kids, and several other donors, Global HOPE launched capacity building programs for pediatric cancer and blood diseases in several Sub-Saharan Africa countries, including in Botswana, Malawi, Kenya, Rwanda, Tanzania and Uganda.
In 2024, Dr. Joseph Lubega became the Director of Global HOPE. He established the first training program for sickle cell disease specialists in Eastern Africa, which has trained 35 physician pioneers whom he continues to mentor. Dr. Lubega is a pediatric hematologist/oncologist with qualifications in public health, implementation science, health cost analysis, and medical leadership.
The Challenge
Sickle cell disease – one of the world’s most neglected diseases
- Sickle cell disease (SCD) is one of the most neglected diseases in the world.
- Sickle cell disease has plagued African children for over 8,000 years. About 300,000 children with sickle cell disease are born every year in sub-Saharan Africa—half of them die before the age of five, accounting for about 16% of mortality in that age group.
- Even their brief life is that of excruciating pain lasting days and disabling strokes. Multiple family members are usually affected—decimating families and causing desperation.
- Interventions to control sickle cell disease are medically simple:
- infant screening,
- immunizations,
- a daily penicillin pill for five years, and
- a daily pill, called hydroxyurea, to reduce sickling.
- These interventions are low-cost and proven to work. They have been implemented in Western countries since the 1980s – dramatically reducing suffering and deaths from sickle cell disease. Pilot projects have shown remarkable effectiveness in Africa as well.
- To date, there are no systematic, large-scale public health control programs in the high-burdened African countries.
Click the button above to learn more about our strategy to transform care in sub-Saharan Africa.
Watch the video below to see a summary of the project:
The grander challenge of pediatric oncology – access to care in low/middle-income countries
The excellent survival of children with cancer in high-income countries is a grand achievement that has been accomplished through five decades of translating biomedical discoveries to the bedside. More than 80% of children with cancer in high-income countries are cured. However, on a worldwide scale, most of the ~400,000 children diagnosed with cancer die because of lack of access to proven effective cancer care in their countries and communities.
Texas Children’s Global HOPE Program believes that discovery of curative therapies has been a grand challenge which the field of pediatric oncology has mostly overcome; however, the unconscionable global disparity in childhood cancer survival due to lack of access to these therapies in most regions of the world is a grander challenge that we must address.
Our Approach
- We support low/middle-income countries to train pediatricians to become certified pediatric hematologists/oncologists through a formal two-year fellowship programs at medical schools in their geographical region.
- When the certified pediatric hematologists/oncologists return to their home countries and institutions, typically national and regional referral hospitals, we support them by:
- Training multi-disciplinary teams particularly nurses, pharmacists, pathologists and administrators;
- Supplementing supplies of medicines and diagnostics; and
- Retrofitting facilities with essential clinical equipment, so that they provide improved curative and palliative care for children with cancer and blood diseases.
- We engage Ministries of Health, corporate businesses, civil society, and community-based associations in the countries to sustain and expand access to care of children with cancer and blood diseases.
- We collect and disseminate systematic clinical outcomes and operational data to inform local policy and planning, adapt evidence-based care to the local context, and replicate improved outcomes across Africa and other low/middle-income countries.
Our Impact
Pediatric Hematology/Oncology Specialists
Botswana has an estimated population of 2.6 million. Based on global childhood cancer incidence, an estimated 80 children develop cancer each year in Botswana. Sickle cell disease is relatively rare in Botswana because the country is not endemic for malaria, which is a key geographical factor associated with sickle cell disease.
Texas Children’s Hospital started supporting Pediatric Hematology/Oncology care in Botswana in 2007 by sending specialists to treat children at Princess Marina Hospital in the capital – Gaborone. At the time, less than ten (10) children were diagnosed and treated in the country while a few others traveled to neighboring South Africa for care.
Through Global HOPE’s capacity building efforts, Botswana now has three (3) pediatric oncologists and Princess Marina Hospital diagnoses and treats about 50 children with cancer annually, which is 60% of all cases in the country. A current target of our collaborative efforts is that Botswana will become the first African country where all, 100%, of children with cancer are diagnosed and have access to specialty care.
Katlego Tsimane
Dr. Tsimane is the first native Motswana pediatric oncologist in Botswana. She leads pediatric cancer care at Princess Marina Hospital/Baylor Foundation Botswana in Gaborone.
Mamiki Chise
Dr. Chise completed her pediatric oncology fellowship at University of Cape Town/Red Cross World War II Memorial Hospital in South Africa in 2024, and will join the pediatric oncology team at Princess Marina Hospital/Baylor Foundation Botswana.
Robert Kimutai
Clinical Head at Botswana Baylor Children’s Centre of Clinical Excellence, Dr. Kimutai has a medical degree from the University of Nairobi, and specializes in hematologic & cancer care, and building regional healthcare capacity.
Malawi has an estimated population of 20.4 million. Based on global childhood cancer incidence, an estimated 1,100 children develop cancer each year in Malawi. Sickle cell disease is endemic in Malawi; about 2,000 babies are born with sickle cell disease annually.
In 2013, Baylor College of Medicine Children’s Foundation-Malawi started supporting pediatric cancer care in Lilongwe, the capital of Malawi, with an initial focus on HIV-related cancers, particularly Kaposi sarcoma. In 2015, Global HOPE initiated comprehensive childhood cancer care led by expat specialists from Texas Children’s at Kamuzu Central Hospital – a national referral hospital in Lilongwe. There is a second children’s cancer treatment center in Blantyre, the commercial center of Malawi.
Through Global HOPE’s capacity building efforts, there are now two (2) indigenous pediatric hematologist/oncologists in Lilongwe and Kamuzu Central Hospital who diagnose and treat about 180 children with cancer and 200 with non-cancer blood diseases annually. Global HOPE has also trained a team of 18 pediatric cancer nurses at Kamuzu Central Hospital, in addition to other health professionals.
Atupele Mpasa
Dr. Mpasa is a pediatric hematologist-oncologist at Kamuzu Central Hospital/Baylor Foundation Malawi in Lilongwe. She completed her fellowship in pediatric hematology-oncology at Muhimbili University of Health and Allied Sciences in 2024.
Rizine Mzikamanda
Dr. Mzikamanda is Medical Director of Pediatric Hematology-Oncology at Kamuzu Central Hospital/Baylor Foundation Malawi in Lilongwe. He completed his fellowship at Makerere University in Kampala Uganda. He conducts clinical & implementation research in childhood leukemia & lymphoma.
Uganda has an estimated population of 47 million. Based on global childhood cancer incidence, an estimated 2,800 children develop cancer each year in Uganda. Sickle cell disease is endemic in Uganda; about 15,000 babies are born with sickle cell disease annually.
In 2016, Global HOPE partnered with Makerere University, Ministry of Health and its affiliated clinical institutions to establish one of the first formal pediatric hematology-oncology fellowship training programs in the region. Over 20 specialists have graduated from the fellowship program since 2016, many of them are the designated leaders in the field in their countries, national or regional referral hospitals and universities.
Two additional pediatric cancer treatment centers were established by Global HOPE-trained specialists, doubling the number of children accessing specialized cancer care in the country. Global HOPE-trained specialists also established the first pediatric blood disease specialist treatment centers in the country. In Kampala, the capital of Uganda, Mulago National Referral Hospital is now one of the largest pediatric hematology and oncology centers in Africa – led by nine specialists treat about 1,100 children with sickle cell disease, diagnose 300 children with cancer annually, and have established a dedicated pediatric brain tumor service.
Victoria Mwebe
Dr. Mwebe is a pediatric hematologist-oncologist at Mulago National Referral Hospital. She is a super-specialist in pediatric brain tumors, having completed an additional one-year fellowship in brain and solid tumors at Texas Children’s Hospital.
Catherine Nabaggala
With a medical degree from Makerere University, Dr. Nabaggala specializes in hematologic conditions, sickle cell disease management, advocacy, training and improving pediatric cancer outcomes through clinical care & research.
Catherine Abala
With a medical degree from Mbarara University of Science and Technology, Dr. Abala specializes in pediatric hematologic conditions, sickle cell disease management, advocacy, and research and training initiatives focused on improving pediatric cancer outcomes.
Annet Nakirulu
With a medical degree from Kampala International University, Dr. Nakirulu specializes in hematologic conditions, sickle cell disease management, pediatric palliative care, advocacy, training, and improving outcomes through clinical care & research.
Ruth Namazzi
A Lecturer at Makerere University College of Health Sciences, Dr. Namazzi specializes in hematologic conditions, sickle cell disease, childhood hemolytic anemias, and advancing pediatric cancer care through research and training.
Jennifer Zungu
Located at the Joint Clinical Research Centre in Kampala, with a medical degree from Makerere University, Dr. Zungu is focused on healthcare management, and enhancing cancer outcomes via clinical care, research & training.
Barnabas Atwiine
Lecturer at Mbarara University of Science and Technology, and Head of Mbarara Regional Referral Hospital Cancer Service, Dr. Atwiine specializes in hematology & oncology, as well as improving access to care for sickle cell disease and hemophilia.
Deo Munube
Honorary Lecturer at Mulago National Referral Hospital, with a medical degree from Makerere University, Dr. Munube specializes in cancer & hematology care, immunization, and enhancing cancer care through innovative research and training.
Anne Akullo
At the Joint Clinical Research Center in Kampala, Dr. Akullo is a Makerere University graduate, focusing on hematologic and cancer care, immunization, and enhancing services through clinical leadership, research and health policy advocacy.
Siyadora Ankunda
At Mbarara Regional Referral Hospital, Dr. Ankunda specializes in pediatric hematology & oncology with medical training from Makerere University and Mbarara University of Science and Technology.
Tanzania is a vast country with an estimated population of 66 million. Based on global childhood cancer incidence, an estimated 3,500 children develop cancer each year in Tanzania. Sickle cell disease is endemic in Tanzania; about 11,000 babies are born with sickle cell disease annually.
In 2020, Global HOPE partnered with Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, to establish a second formal pediatric hematology-oncology fellowship training program in the region, led by one of the graduates from the Makerere University/Global HOPE fellowship program, Dr. Lulu Chirande. Five specialists have graduated from the MUHAS fellowship program since 2020.
Global HOPE-trained specialists currently lead pediatric hematology and oncology care in all regions of Tanzania, including Dar es Salaam in the southeast at Muhimbili National Hospital and Aga Khan Hospital, Mwanza (Lake Zone) in the northwest at Bugando Medical Center, Mbeya (Mountain Zone) in the southwest at Mbeya Regional Referral Hospital, and the island of Zanzibar at Mnazi Moja Hospital. Fellows from Dodoma (Central) and Kilimanjaro (northeast) are currently in training.
Heronima Joas Kashaigili
Lecturer at Bugando Medical Centre/Catholic University of Allied and Health Sciences, Dr. Joas Kashaigili specializes in hematology, cancer care, and improving survival rates through early diagnosis, quality management and clinical research.
Sonal Patel
Located at Aga Khan Hospital in Dar Es Salaam, Tanzania, Dr. Patel specializes in childhood cancer care, sickle cell disease, and improving quality of life for children through education and community health initiatives.
Nana Nakiddu
Lecturer at Muhimbili University of Health and Allied Sciences, Dr. Nakiddu specializes in pediatric hematology, cancer survivorship and sports medicine, with a focus on expanding care networks and training in Uganda and Tanzania.
Furaha Prosper Kyesi
Secretary General of the Paediatric Association of Tanzania, Dr. Kyesi specializes in pediatric hematology & oncology, immunization and public health, with a focus on research into improving survival rates and quality of life.
Bambi Nsalazi Emma
At Kenya's LifeCare Group of Hospitals, Dr. Nsalazi Emma has a medical degree from the University of Goma, and specializes in nutrition, and advancing the cancer and sickle cell disease care through early detection, capacity building and community engagement.
Anna Magembe
At Mbeya Zonal Referral Hospital, Dr. Magembe specializes in pediatric hematology & oncology with medical training from Kilimanjaro Christian Medical Center and Muhimbili University of Health and Allied Sciences.
Moses Karashani
Fathiya Al-Oufy
Dr. Al-Oufy is a pediatric hematologist-oncologist at Mnazi Mmoja Hospital in Zanzibar, where she leads the care of children with focus on thalassemia.
Lulu Chirande
A Senior Lecturer at and head of the pediatric hematology-oncology fellowship at Muhimbili University of Health and Allied Sciences. She is also Consultant at Muhimbili National Hospital, and leads Tanzania’s sickle cell disease scale-up initiatives.
Christine Kindole
At Muhimbili National Hospital, with a medical degree from Muhimbili University of Health and Allied Sciences, Dr. Kindole is advancing cancer and sickle cell disease care and treatment guidelines, while building international research collaborations.
Regina Kabona
At Muhimbili National Hospital, Dr. Kabona specializes in pediatric hematology & oncology with medical training from the University of Dar es Salaam and Muhimbili University of Health and Allied Sciences.
Kenya has an estimated population of 54 million. Based on global childhood cancer incidence, an estimated 3,000 children develop cancer each year in Kenya. Sickle cell disease is endemic in Kenya; about 14,000 babies are born with sickle cell disease annually.
At its affiliated fellowship programs in Uganda and Tanzania, Global HOPE has trained six (6) of Kenya’s first pediatric hematology/oncology specialists including the current leaders of clinical services at Kenyatta National Referral Hospital and Kenyatta University Teaching Research and Referral Hospital in Nairobi, and Kisii County Hospital in the southwest of Kenya.
Irene Nzamu
At Kenyatta National Hospital, with a medical degree from the University of Nairobi, Dr. Nzamu specializes in pediatric cancer and palliative care, and improving outcomes through early detection, multidisciplinary care and national health initiatives.
Catherine Muendo
At Kenyatta National Hospital, Dr. Muendo is Vice Chair of the Paediatric Hematology Oncology Society of Kenya, and Chair of Kenya’s Ministry of Health taskforce for early detection of childhood cancer.
Rose Munge
Head of Pediatric Hematology & Oncology at Kenyatta University Teaching Research and Referral Hospital, Dr. Munge specializes in establishing oncology services, and advancing evidence based-care through research, leadership and training opportunities.
Bernice Mukuria
In Nairobi, Dr. Mukuria specializes in childhood cancer and blood disorders, and advocacy and policy implementation, with a medical degree from the University of Nairobi and additional training in Leadership & Management in Health.
Deborah Omeddo
At Kisii Teaching and Referral Hospital, Dr. Omeddo is Head of the Department of Pediatrics, and specializes in pediatric cancer & blood disorders, quality, patient safety and improving access to care for children in rural Kenya.
Rwanda is one of the world’s most densely populated countries with a population of about 14 million. Based on global childhood cancer incidence, an estimated 700 children develop cancer and about 420 are born with sickle cell disease each year in Rwanda
In 2023, Global HOPE supported the establishment of the first pediatric cancer treatment service at Centre Hospitalier Universitaire de Kigali (CHUK) by installing a modern chemotherapy pharmacy and kick starting access to anticancer drugs.
Aimable Kanyamuhunga
Dr. Kanyamuhunga is Associate Professor and Chair of Pediatrics at University of Rwanda, College of Medicine & Health Sciences. He completed his pediatric hematology-oncology fellowship at Stellenbosch University/Tygerberg Hospital, Cape Town.
Established in 2011, South Sudan is one of the world’s newest countries. It has a population of about 12 million. Based on global childhood cancer incidence, an estimated 520 children develop cancer and about 6,000 are born with sickle cell disease each year in South Sudan.
Global HOPE has trained two pediatric hematologist/oncologists who lead sickle cell disease care at Al Sabbah Children Hospital in Juba. They also care for children with cancer by providing initial diagnosis and referral for treatment to Uganda or other children’s cancer centers in the region.
Joseph Gore
Dr. Gore is Head of the Pediatric Hematology & Oncology Unit at Alsabbah Children Hospital in Juba, and Senior Lecturer at the University of Juba, with a focus on improving sickle cell disease care & oncology services in South Sudan.
Sarra James
At Alsabah Children Hospital in Juba, Dr. James specializes in cancer & blood disorders, with extensive experience in health systems in Africa, focusing on improving sickle cell disease care, mentoring junior doctors, and increasing pediatric cancer awareness.
Namibia has a population of about 2.8 million. Based on global childhood cancer incidence, an estimated 100 children develop cancer each year in Namibia. Sickle cell disease is relatively rare in Namibia because the country is not endemic for malaria, which is a key geographical factor associated with sickle cell disease.
Innocent Adogah
Dr Adogah is a Pediatrician, Paediatric Haematologist-Oncologist, and Head of Paediatric Department at Engela State Hospital in Ohangwena Region, Namibia.
Current Fellows
Training Programs
- Makerere University Kampala, Uganda
- Muhimbili University of Health and Allied Sciences (MUHAS) Dar es Salaam, Tanzania
- University of Cape Town South Africa
- University of the Witswatersrand (Wits) Johannesburg, South Africa
- Weekly Global HOPE Problem Case Conference
- Nursing Case Study Seminars
- Virtual Nursing Workshop
- Virtual Pediatric Palliative Care Workshop
- Promoting Professional Well-Being
- Quality Improvement in Health Care
- Pain Assessment and Management in Children
- Wound Assessment and Management in Children
- Essentials of Evidence-Based Practice
- Essentials of Pediatric Oncology Nursing
- Chemotherapy
- Cornerstones of Pediatric Nursing
- Pediatric Nursing Skills
- Introduction to Childhood Cancer Nursing
- Pediatric Palliative Care
- Essentials of Pediatric Hematology
- Sickle Cell Disease (English & Portuguese)
- Aseptic Technique
- Medication Safety and Quality Improvement
- Pathology Lecture Series
- Evidence-based Practice Course
- Dissemination and Implementation Science Course
- Quality Improvement in Health Care Course
By The Numbers
Give to Global HOPE
Thank you for supporting the Global Hematology-Oncology Pediatric Excellence (HOPE) program at Texas Children's Hospital. Your gift helps us provide the treatments needed to improve the prognosis for children with cancer and blood disorders in sub-Saharan Africa.
Our Team
Our Team
Medical and Scientific Leadership and Consultants
Joseph Lubega, MD, MSPH, CPE
Director, Global HOPE, Texas Children's Cancer and Hematology Center
Associate Professor, Department of Pediatrics, Section of Oncology-Hematology,
Baylor College of Medicine
Nmazuo W. Ozuah, MD
Associate Director, Global Hematology-Oncology Pediatric Excellence (HOPE), Texas Children's Cancer and Hematology Center
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Marilyn Hockenberry, PhD, RN, CPNP-BC, FAAN
Director for Nursing and Education, Global HOPE, Texas Children's Cancer and Hematology Center
Professor, Department of Pediatrics, Section of Oncology-Hematology, Baylor College of Medicine
Julie M. Gastier-Foster, PhD, FACMG
Director of Laboratory and Pathology, Global HOPE
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Casey McAtee, MD, MPH
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Peter Wasswa, MD, FRCPath
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Consultants
- Gladstone E. Airewele, MD, MPH
- Carl E. Allen, MD, PhD
- Lisa R. Bomgaars, MD, MS
- Murali M. Chintagumpala, MD
- ZoAnn E. Dreyer, MD
- Tarek Elghetany, MD
- Ernest D. Fruge, PhD
- Karen Gibbs, RN, MSN/MPH, PhD
- John M. Hicks, MD, PhD, DDS
- YoungNa J. Lee-Kim, MD, MEd
- Andrea N. Marcogliese, MD
- Judith F. Margolin, MD
- Bip Nandi, MD
- Jed G. Nuchtern, MD
- Nino C. Rainusso, MD
- Michael Scheurer, PhD, MPH, FACE
- Venee N. Tubman, MD, MMSc
- Mark C. Zobeck, MD, MPH
Governance
Debra F. Sukin, MHA, PhD, FACHE
Chief Executive Officer and President - Texas Children's Hospital
Daniel DiPrisco, MHA
President – Texas Children’s Global
Paola Alvarez-Malo
Vice President - Texas Children's Global HOPE
Susan M. Blaney, MD
Director - Texas Children's Cancer & Hematology Center
Lara Shekerdemian, MD, MHA
Pediatrician In-Chief and Chair of the Department of Pediatrics - Baylor College of Medicine
Paul Klotman, MD, FACP
President & CEO - Baylor College of Medicine
Advisory Council
Dr. Cary Adams
CEO, Union for International Cancer Control (UICC)
Dr. James S Allen
Senior Consulting Health Scientist, Chevron Energy Technology Company
Veronica Arroyave
Senior Director, Global Community Relations, Executive Director, Baxter International Foundation
Guy Baron
Director, Tony Blair Institute for Global Change
Anthony Carroll
Vice President, Manchester Trade Limited
John Damonti
Advisor, Texas Children’s Global HOPE
Charles L. Frankel
Honorary Consul of the Republic of Botswana
Hemant Goradia
President and CEO, Vinmar International Ltd.
Catharine Grimes
President, Bristol Myers Squibb Foundation
Donald L. Kramer, MD
Honorary Consul of the Republic of Botswana
John Knox Jr.
CEO, Markel Surety Corp.
Hon. Jimmy Kolker
Former United States Ambassador
News
News
Bristol Myers Squibb Foundation, Texas Children’s Global HOPE, & Baylor College of Medicine Global Health launch program to combat sickle cell disease in sub-Saharan Africa (Baylor College of Medicine - January 6, 2025)
The Ugandan hospital tackling childhood cancer (BBC - February 17, 2023)
Global HOPE partners with fellowship program at University of Cape Town to expand access to pediatric hematology-oncology physician training in sub-Saharan Africa (Texas Children's Hospital - November 11, 2021)
Baylor receives more than $20 million in CPRIT funding (Baylor College of Medicine - August 20, 2021)
Global HOPE provides infrastructure for improving pediatric cancer care in Africa (Baylor College of Medicine - September 30, 2020)
US Congressman brings fight against childhood cancer to Africa (Daily Maverick - March 21, 2020)
LCIF and Global HOPE partner to fight childhood cancer in Africa (GlobeNewswire - March 6, 2020)
Botswana: First Lady hails efforts to tackle childhood cancer (allAfrica - February 2, 2020)
Rep. McCaul’s Global Hope Act brings lifesaving cancer treatments to children in developing nations (Houston Chronicle - January 3, 2020)
First Lady of the Republic of Botswana is inaugural member of Global HOPE’s International Council (Texas Children's Hospital - June 28, 2019)
Global HOPE initiative in Africa makes great strides during first year (Texas Children's Hospital - April 25, 2019)
Young cancer patients in poor countries get a boost (Wall Street Journal - September 26, 2018)
"Texas Children’s Hospital in Houston has focused on sub-Saharan Africa, where every year more than 100,000 children get cancer and 90% of them die, says David Poplack, a professor of pediatric oncology at Baylor College of Medicine. The initiative he started in 2016 targets three countries: Malawi, Botswana and Uganda—a nation of more than 44 million that two years ago didn’t have a single pediatric oncologist, Dr. Poplack says. A priority of the program, called Global HOPE, is training local pediatricians to become pediatric oncologists. These countries are taking so-called Centers of Excellence—clinics created during the AIDS epidemic—and expanding them to diagnose and treat children with cancer.
Before his program, Dr. Poplack says, in Uganda, “70% of the children who came to the hospital died in the first month.” Now, “85% are surviving one month and over 50% are surviving more than a year and a half.”
Global HOPE earns Fast Company Innovation Design Honors (Cannon Design - September 10, 2018)
Thinking globally to help families battling childhood cancer (American Academy of Pediatrics - September 17, 2018)
First class of the East African Pediatric Hematology and Oncology Fellowship Program graduates (Bristol-Myers Squibb - August 27, 2018)
Makerere University awards Dr. Poplack, Late Ryoichi Sasakawa Honorary Doctorates (Campus Times - August 10, 2018)
MAK honours doctor's hand in fight against cancer in children (New Vision - August 9, 2018)
Dr. Poplack, Ryoichi Sasakawa receive Mak’s Prestigious Honorary Doctorates (Makerere University Vision - August 9, 2018)
Jackson doc's work saves lives in Africa (Jackson Hole News & Guides - August 1, 2018)
New leadership at Texas Children’s Cancer Center (Houston Chronicle - July 9, 2018)
Cancer and Hematology Centers announce transition in leadership (Texas Children's Hospital - July 5, 2018)
Lukolyo to serve on committee on global child health (Baylor College of Medicine - May 11, 2018)
Global HOPE initiative in Africa makes great strides during first year (Texas Children's Hospital - April 24, 2018)
Baylor, Texas Children's cancer initiative in Africa hits milestone (Houston Chronicle - April 9, 2018)
Cancer on the rise among children from poor families (New Vision - February 6, 2018)
Cancer on the rise among children (New Vision - February 5, 2018)
Global HOPE supports parent-led advocacy group in Uganda (Texas Children's Hospital - February 5, 2018)
Offering HOPE to pediatric oncology patients around the globe (Oncology Times - November 25, 2017)
International scholar in Uganda gives kids with cancer hope (St. Baldrick’s Foundation - September 25, 2017)
Ladies Circle of Botswana Happy Hearts Project (Texas Children's Hospital - June 05, 2017)
Changing the pediatric cancer landscape in Africa (Baylor College of Medicine - May 03, 2017)
Touched by Grace (KOLN 1011 News - March 31, 2017)
How a blueprint for Treating HIV/AIDS Is helping address childhood cancer in Africa (Philanthropy News Digest - March 21, 2017)
Can we fight childhood cancer in Africa the same way we fought HIV? (Texas Children's Hospital - March 09, 2017)
First comprehensive pediatric hematology-oncology initiative launched in Africa (Texas Children's Hospital - February 21, 2017)
Baylor, Texas Children’s take pediatric cancer fight to Africa (Houston Chronicle - February 21, 2017)
Dr. Lubega devoted to tackling child cancers (The Observer - February 18, 2017)
Giving a Texas touch to children’s cancer treatment in Uganda (Christine Namulindwa Blog - January 04, 2017)
What I learned from training nurses in Botswana (Voice of Nursing - October 26, 2016)
Baylor and Texas Children’s Hospital partner to bring fellowship training in oncology and hematology to East Africa (Baylor College of Medicine - October 26, 2016)
New Pediatric Oncology Training Program bridges the gap for kids in Africa (St. Baldrick’s - September 29, 2016)
Texas Children’s Cancer Center extends its global impact (Texas Children's Hospital - August 01, 2016)
Global health initiative helps provide medication to African children with sickle cell (Texas Children's Hospital - June 29, 2016)
Angola Sickle Cell Initiative teaming with Bristol-Myers Squibb to provide children with medication for sickle cell disease (Texas Children's Hospital - June 24, 2016)
First-of-its-kind children’s cancer center launches in Botswana capital (Texas Children's Hospital - June 15, 2016)
Texas Children’s expands crucial care to cancer and hematology patients in developing countries (Texas Children's Hospital - July 28, 2015)
Making an impact on oncology training in Botswana (Texas Children's Hospital - December 31, 2014)
International Scholars from Princess Marina Hospital visit for training (Texas Children's Hospital - October 22, 2013)